Top Quality 21462-39-5 - Tadalafil 171596-29-5 Hormone and endocrine ED treatment – Neore
Top Quality 21462-39-5 - Tadalafil 171596-29-5 Hormone and endocrine ED treatment – Neore Detail:
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 500kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information: Not dangerous goods
Introduction
Tadalafil, is a medication used to treat erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension.
Specification (USP42)
Item |
Specification |
Appearance |
White or almost white powder |
Solubility |
Freely soluble in dimethyl sulfoxide, slightly soluble in methylene chloride and practically insoluble in water. |
Identification |
IR, HPLC |
Loss on drying | ≤0.5% |
Residue on ignition | ≤0.10% |
Enantiomeric and Dia-stereomeric purity By HPLC | 6R,12aS Dia-stereomer ≤0.1% |
6S,12aS Enantiomer ≤0.1% | |
6S,12aR Dia-stereomer ≤0.1% | |
Chromatographic Purity by HPLC | Individual impurity ≤0.1% |
Total impurities ≤0.3% | |
Assay by HPLC (on dried basis) | 97.5%~102.5% |
Product detail pictures:
Related Product Guide:
"Based on domestic market and expand overseas business" is our development strategy for Top Quality 21462-39-5 - Tadalafil 171596-29-5 Hormone and endocrine ED treatment – Neore , The product will supply to all over the world, such as: Casablanca, Honduras, Colombia, If you need any of our products, or have other items to be produced, please send us your inquiries, samples or detailed drawings. Meanwhile, aiming to develop into an international enterprise group, we look forward to receiving offers for joint ventures and other cooperative projects.
By Amber from Peru - 2017.03.28 16:34
We are a small company that has just started, but we get the company leader's attention and gave us a lot of help. Hope we can make progress together!
By Eunice from America - 2017.05.02 11:33